Vulnerability · CVE-2025-9715
A vulnerability was found in O2OA up to 10.0-410.
Published Aug 31, 2025 · catalog updated Oct 19, 2026 · O2OA
Check this week
CVE-2025-9715 is not in CISA KEV. FIRST estimates a 33.00% chance of exploitation in the next 30 days. Check whether you run O2OA.
Gaps on this record
- No vendor fix or required action is stored. Compare the linked advisory before you change production.
- Severity
- Medium5.1
- Known exploitation
- Not in CISA/VulnCheck KEV
- EPSS
- 33.00%
- Remediation
- Advisory link
- Affected products
- cpe zoneland/o2oa · vendor n/a O2OA 10.0-410
A vulnerability was found in O2OA up to 10.0-410. Affected is an unknown function of the file /x_cms_assemble_control/jaxrs/script of the component Personal Profile Page. The manipulation of the argument name/alias/description results in cross site scripting. The attack can be launched remotely. The exploit has been made public and could be used. The vendor replied in the GitHub issue (translated from simplified Chinese): "This issue will be fixed in the new version."
Are you affected?
Enter the version you run. The result uses only the ranges stored on this record.
The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.
- cpe zoneland/o2oaversion unspecified
- vendor n/a O2OA 10.0-41010.0-410
How to fix CVE-2025-9715
Recommended remediation
A patch or advisory reference is linked. Open the original publisher for availability by product version.
Official advisories
What to do
Three questions, each answered from this record only. Confirm the vendor advisory before you patch.
Should you patch?
CVE-2025-9715 is not in CISA KEV. FIRST estimates a 33.00% chance of exploitation in the next 30 days. Check whether you run O2OA.
Which versions are affected?
Compare what you have installed with n/a O2OA 10.0-410 10.0-410. Compare the installed version with the linked vendor advisory before you change production.
What should an analyst verify?
CWE-79: Cross-site Scripting (XSS); CWE-94: Code Injection. EPSS 33.00%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.
Code
The project this record applies to. Exploit listings stay in References.
No public source repository is identified for this product.
Timeline
Detection, updates, and resolution for this record.
Aug 31, 2025 · NIST NVD
Detected
A vulnerability was found in O2OA up to 10.0-410. Affected is an unknown function of the file /x_cms_assemble_control/jaxrs/script of the component Personal Profile Page. The manipulation of the argument name/alias/description results in cross site scripting. The attack can be launched remotely. The exploit has been made public and could be used. The vendor replied in the GitHub issue (translated
Oct 19, 2026 · NIST NVD
Updated
A vulnerability was found in O2OA up to 10.0-410. Affected is an unknown function of the file /x_cms_assemble_control/jaxrs/script of the component Personal Profile Page. The manipulation of the argument name/alias/description results in cross site scripting. The attack can be launched remotely. The exploit has been made public and could be used. The vendor replied in the GitHub issue (translated
Sources
- CVE.orgVulnerability recordCVE-2025-9715
Official CVE identifier
cve.org - EUVDVulnerability recordEUVD-2025-28880
A vulnerability was found in O2OA up to 10.0-410. Affected is an unknown function of the file /x_cms_assemble_control/jaxrs/script of the component Personal Profile Page. The manipulation of the argument name/alias/description results in cross site scripting. The attack can be la
euvd.enisa.europa.eu - NIST NVDVulnerability recordCVE-2025-9715
A vulnerability was found in O2OA up to 10.0-410. Affected is an unknown function of the file /x_cms_assemble_control/jaxrs/script of the component Personal Profile Page. The manipulation of the argument name/alias/description results in cross site scripting. The attack can be la
nvd.nist.gov
References
Freshness
Last verified in this catalog Oct 19, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.